Business Wire IndiaCitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader in the HFS Horizons: Life Sciences Service Providers, 2023 report. The HFS Horizons report meticulously examines the capabilities of 29 service providers across key dimensions such as value proposition, innovation capabilities, go-to-market strategy, and market impact. CitiusTech excelled in these categories, securing its position as a market leader.
This comprehensive report evaluates service providers in the global life sciences industry, covering pharmaceuticals, MedTech, contract research organizations (CROs), and distributors. In recognizing CitiusTech, the report highlighted the company's domain specialization, products, solutions, and strong consulting-led approach. The strengths include deep domain expertise, complex data management, and engineering capabilities across the life sciences value chain.
Rohan Kulkarni, Practice Leader – Healthcare and Life Sciences Research, HFS said, “CitiusTech's life sciences and healthcare only focus drives meaningful impact across the triple aim of care, delivering improved health outcomes by supporting clinical treatment pathways, address fair pricing of drugs through automation, and leverages it advisory to drive outcome-based offerings.”
“Enabling digital transformation through domain expertise, innovation and an unwavering commitment to outcomes is not just a strategy – it is in our DNA,” said Shreejit Nair, Senior Vice President – Life Sciences, CitiusTech. “Being recognized as a market leader by HFS Research underscores CitiusTech's commitment to driving innovation in life sciences. Our unique strength lies in the power of domain specialization, propelling us to perfect the value chain and deliver outcomes that truly enables convergence across the healthcare ecosystem and impacts cost, health outcomes, and experiences.”
CitiusTech’s strengths noted in the report include:
With over 140 clients globally, including seven of the world's top 15 medical device companies, four of the top 10 global pharma companies, and three of the top seven CROs, CitiusTech continues to expand its global operations with over 8500 employees worldwide.
To download the full report, please click here.
This website uses cookies.